A Multicenter Phase 2a Clinical Study to Evaluate SIM0278 in Subjects With Active Lupus Nephritis
NCT07393451
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Lupus Nephritis
Interventions
DRUG:
SIM0278 injection
Sponsor
Simcere Pharmaceutical Co., Ltd